The Indices of Cardiovascular Magnetic Resonance Derived Atrial Dynamics May Improve the Contemporary Risk Stratification Algorithms in Children with Hypertrophic Cardiomyopathy
- PMID: 33567718
- PMCID: PMC7915130
- DOI: 10.3390/jcm10040650
The Indices of Cardiovascular Magnetic Resonance Derived Atrial Dynamics May Improve the Contemporary Risk Stratification Algorithms in Children with Hypertrophic Cardiomyopathy
Abstract
Introduction: The most efficient risk stratification algorithms are expected to deliver robust and indefectible identification of high-risk children with hypertrophic cardiomyopathy (HCM). Here we compare algorithms for risk stratification in primary prevention in HCM children and investigate whether novel indices of biatrial performance improve these algorithms.
Methods and results: The endpoints were defined as sudden cardiac death, resuscitated cardiac arrest, or appropriate implantable cardioverter-defibrillator discharge. We examined the prognostic utility of classic American College of Cardiology/American Heart Association (ACC/AHA) risk factors, the novel HCM Risk-Kids score and the combination of these with indices of biatrial dynamics. The study consisted of 55 HCM children (mean age 12.5 ± 4.6 years, 69.1% males); seven had endpoints (four deaths, three appropriate ICD discharges). A strong trend (DeLong p = 0.08) was observed towards better endpoint identification performance of the HCM Risk-Kids Model compared to the ACC/AHA strategy. Adding the atrial conduit function component significantly improved the prediction capabilities of the AHA/ACC Model (DeLong p = 0.01) and HCM Risk-Kids algorithm (DeLong p = 0.04).
Conclusions: The new HCM Risk-Kids individualised algorithm and score was capable of identifying high-risk children with very good accuracy. The inclusion of one of the atrial dynamic indices improved both risk stratification strategies.
Keywords: atrial strain; hypertrophic cardiomyopathy; outcome; risk markers.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Maron B.J., Ferrans V.J., Henry W.L., Clark C.E., Redwood D.R., Roberts W.C., Morrow A.G., Epstein S.E. Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH): Light and electron microscopic findings. Circulation. 1974;50:436–446. doi: 10.1161/01.CIR.50.3.436. - DOI - PubMed
-
- Brouwer W.P., Baars E.N., Tjeerd G., de Boer K., Beek A.M., van der Velden J., van Rossum A.C., Mark B.M.H. In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy. J. Cardiovasc. Magn. Reson. 2014;16:28. doi: 10.1186/1532-429X-16-28. - DOI - PMC - PubMed
-
- Maron B.J., Spirito P., Ackerman M.J., Casey S.A., Semsarian C., Estes N.A.M., III, Shannon K.M., Ashley E.A., Day S.M., Pacileo G., et al. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2013;61:1527–1535. doi: 10.1016/j.jacc.2013.01.037. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
